Noël, Agnès ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie cellulaire et moléculaire appliquée à l'homme
Chenard, M. P.
Wolf, C.
Anglard, P.
Rio, M. C.
Language :
English
Title :
Stromelysin-3: a paradigm for stroma-derived factors implicated in carcinoma progression."
Dvorak, H.F., Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing (1986) N Engl J Med, 315, pp. 1650-1659
Van Den Hoof, A., Stromal involvement in malignant growth (1988) Adv Cancer Res, 50, pp. 159-196
Van Scott, E.J., Reinerston, R.P., The modulating influence of stromal environment on epithelial cells studied in human autotransplants (1961) J Invest Dermatol, 36, pp. 109-131
Sakakura, T., Sakagami, Y., Nishizuka, Y., Accelerated mammary cancer development by fetal salivary mesenchyma isografted to adult mouse mammary epithelium (1981) J Natl Cancer Inst, 66, pp. 953-959
Cunha, G.R., Hom, Y.K., Role of mesenchymal-epithelial interactions in mammary gland development (1996) J Mammary Gland Biol Neoplasia, 1, pp. 21-35
Hanahan, D., Folkman, J., Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis (1996) Cell, 86, pp. 353-364
Zipori, D., Stromal cells in tumor growth and regression (1990) Cancer J, 3, pp. 164-169
Basset, P., Bellocq, J.P., Wolf, C., A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas (1990) Nature, 348, pp. 699-704
Pyke, C., Kristensen, P., Ralfkiaer, E., Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas (1991) Am J Pathol, 138, pp. 1059-1067
MacDougall, J.R., Matrisian, L.M., Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis (1995) Cancer Metast Rev, 14, pp. 351-362
Mignatti, P., Rifkin, D.B., Biology and biochemistry of proteinases in tumor invasion (1993) Physiol Rev, 73, pp. 161-195
Duffy, M.J., Proteases as prognostic markers in cancer (1996) Clin Cancer Res, 2, pp. 613-618
Stetler-Stevenson, W.G., Hewitt, R., Corcoran, M., Matrix metalloproteinases and tumor invasion: From correlation and causality to the clinic (1996) Cancer Biol, 7, pp. 147-154
Liotta, L.A., Cancer cell invasion and metastasis (1992) Sci Am, 266 (2), pp. 34-41
Coussens, L.M., Werb, Z., Matrix metalloproteinases and the development of cancer (1996) Chem Biol, 15, pp. 535-541
Basset, P., Okada, A., Chenard, M.P., Matrix metalloproteinases as stromal effectors of human carcinoma progression: Therapeutical implications (1997) Matrix Biol, 15, pp. 535-541
Matrisian, L.M., Metalloproteinases and their inhibitors in matrix remodeling (1990) Trends Genet, 6, pp. 121-125
Stöcker, W., Bode, W., Structural features of a superfamily of zinc-endopeptidases: The metzincins (1995) Curr Opin Struct Biol, 5, pp. 383-390
Lefebvre, O., Wolf, C., Limacher, J.M., The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apotosis (1992) J Cell Biol, 119, pp. 997-1002
Okada, A., Saez, S., Misumi, Y., Basset, P., Rat stromelysin 3: CDNA cloning from healing skin wound, activation by furin and expression in rat tissues (1997) Gene, 185, pp. 187-193
Patterton, D., Hayes, W.P., Shi, Y.B., Transcriptional activation of the matrix metalloproteinase gene stromelysin-3 coincides with thyroid hormone-induced cell death during frog metamorphosis (1995) Dev Biol, 167, pp. 252-262
Birkedal-Hansen, H., Proteolytic remodeling of extracellular matrix (1995) Curr Opin Cell Biol, 7, pp. 728-735
Murphy, G.J.P., Murphy, G., Reynolds, J.J., The origin of matrix metalloproteinases and their familial relationships (1991) FEBS Lett, 289, pp. 4-7
Levy, A., Zucman, J., Delattre, O., Mattei, M.G., Rio, M.C., Basset, P., Assignment of the human stromelysin-3 (STMY3) gene to the q11.2 region of chromosome 22 (1992) Genomics, 13, pp. 881-883
De Souza, S.J., Brentani, R., Sequence homology between a bacterial metalloproteinase and eukaryotic matrix metalloproteinases (1993) J Mol Evol, 36, pp. 596-598
Woessner, J.F., The family of matrix metalloproteinases (1994) Ann NY Acad Sci, 732, pp. 11-21
Takahashi, S., Hatsuzawa, K., Watanabe, T., Murakami, K., Nakayama, K., Sequence requirements for endoproteolytic processing of precursor proteins by furin: Transfection and in vitro experiments (1994) J Biochem, 116, pp. 47-52
Pei, D., Weiss, S.J., Furin-dependent intracellular activation of the human stromelysin-3 zymogen (1995) Nature, 375, pp. 244-247
Santavicca, M., Noël, A., Angliker, H., Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertases (1996) Biochem J, 315, pp. 953-958
Murphy, G., Segain, J.P., O'Shea, M., The 28 kDa N-terminal domain of mouse stromelysin-3 has the general properties of a weak metalloproteinase (1993) J Biol Chem, 268, pp. 15435-15441
Pei, D., Majmudar, G., Weiss, S.J., Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3 (1994) J Biol Chem, 269, pp. 25849-25855
Noël, A., Santavicca, M., Stoll, I., Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities (1995) J Biol Chem, 270, pp. 22866-22872
Sires, U.I., Murphy, G., Baragi, V.M., Fliszar, C.J., Welgus, H.G., Senior, R.M., Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of a1-antitrypsin (1994) Biochem Biophys Res Commun, 204, pp. 613-620
Zhang, Z., Winyard, P.G., Chidwick, K., Proteolysis of human native and oxidised alpha 1-proteinase inhibitor by matrilysin and stromelysin (1994) Biochim Biophys Acta, 1199, pp. 224-228
Rawlings, N.D., Barrett, A.J., Evolutionary families of metallopeptidases (1995) Methods Enzymol, 248, pp. 183-228
Urbanski, S.J., Edwards, D.R., Maitland, A., Leco, K.J., Watson, A., Kossakowska, A.E., Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas (1992) Br J Cancer, 66, pp. 1188-1194
Wagner, S.N., Ruhri, C., Kunth, K., Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma (1992) Diagn Mol Pathol, 3, pp. 200-205
Wolf, C., Chenard, M.P., Durand De Grossouvre, P., Bellocq, J.P., Chambon, P., Basset, P., The breast cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing (1992) J Invest Dermatol, 99, pp. 870-872
Muller, D., Wolf, C., Abecassis, J., Increased stromelysin-3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas (1993) Cancer Res, 53, pp. 165-169
Wolf, C., Rouyer, N., Lutz, Y., Stromelysin-3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression (1993) Proc Natl Acad Sci USA, 90, pp. 1843-1847
Hähnel, E., Harvey, J.M., Joyce, R., Robbins, P.D., Sterrett, G.F., Hähnel, R., Stromelysin-3 expression in breast cancer biopsies: Clinico-pathological correlations (1993) Int J Cancer, 55, pp. 771-774
Kawami, H., Yoshida, K., Ohsaki, A., Kuroi, K., Nishiyama, M., Toge, T., Stromelysin-3 mRNA expression and malignancy: Comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors (1993) Anticancer Res, 13, pp. 2319-2324
Polette, M., Clavel, C., Birembaut, P., De Clerek, Y.A., Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas (1993) Pathol Res Pract, 189, pp. 1052-1057
Bellocq, J.P., Chenard-Neu, M.P., Rouyer, N., Wolf, C., Chambon, P., Basset, P., Stromelysin-3 gene expression in breast and other human carcinomas (1993) Prospects in Diagnosis and Treatment of Breast Cancer, pp. 187-197. , Schmitt M, Graeff H, Kindermann G, editors. Munich: Elsevier
Urbanski, S.J., Edwards, D.R., Hershfield, N., Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia (1993) Diagn Mol Pathol, 2, pp. 81-89
Majmudar, G., Nelson, B.R., Jensen, T.C., Voorhees, J.J., Johnson, T.M., Increased expression of stromelysin-3 in basal cell carcinomas (1994) Mol Carcinogen, 9, pp. 17-23
Engel, G., Heseemeyer, K., Auer, G., Backdahl, M., Eriksson, E., Linder, S., Correlation between stromelysin-3 mRNA level and outcome of human breast cancer (1994) Int J Cancer, 58, pp. 830-835
Rouyer, N., Wolf, C., Chenard, M.P., Stromelysin-3 gene expression in human cancer: An overview (1994) Invas Metast, 14, pp. 269-275
Porte, H., Chastre, E., Prevot, S., Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40 SPARC genes (1995) Int J Cancer, 64, pp. 70-75
Anderson, I.C., Sugarbaker, D.J., Ganju, R.K., Stromelysin-3 is overexpressed by stromal elements in primary non-small cell lung cancers and regulated by retinoic acid in pulmonary fibroblasts (1995) Cancer Res, 55, pp. 4120-4126
Heppner, K.J., Matrisian, L.M., Jensen, R.A., Rodgers, W.H., Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response (1996) Am J Pathol, 149, pp. 273-282
Linden, A.B., Sandstedt, B., Bruce, K.L., Hedblad, M.A., Stahle-Bäckdahl, M., Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma (1996) J Invest Dermatol, 107, pp. 147-153
Johnson, L.D., Hunt, D.M., Kim, K., Nachtigal, M., Amplification of stromelysin-3 transcripts from carcinomas of the colon (1996) Hum Pathol, 27, pp. 964-968
Chenard, M.P., O'Siorain, L., Shering, S., High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma (1996) Int J Cancer, 69, pp. 448-451
Grégoire, M., Lieubeau, B., The role of fibroblasts in tumor behavior (1995) Cancer Metast Rev, 14, pp. 339-350
Lane, T.E., Sage, E.H., The biology of SPARC, a protein that modulates cell-matrix interactions (1994) FASEB J, 8, pp. 163-173
Podhajcer, O.L., Wolf, C., Lefebvre, O., Comparative expression of the SPARC and stromelysin-3 genes in mammary tumours (1996) The Breast, 5, pp. 13-20
Rodgers, W.H., Matrisian, L.M., Giudice, L.C., Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones (1994) J Clin Invest, 94, pp. 946-953
Lefebvre, O., Régnier, C., Chenard, M.P., Developmental expression of mouse stromelysin-3 mRNA (1995) Development, 121, pp. 947-955
Okada, A., Tomasetto, C., Lutz, Y., Bellocq, J.P., Rio, M.C., Basset, P., Expression of matrix metalloproteinases during rat skin wound healing: Evidence that membrane-type-1 matrix metalloprotemase (MT1-MMP) is a stromal activator of progelatinase A (1997) J Cell Biol, , in press
Maquoi, E., Polette, M., Nawrocki, M., Expression of stromelysin-3 in the human placenta and placental bed (1997) Placenta, , in press
Hähnel, E., Dwakins, H., Robbins, P., Hähnel, R., Expression of stromelysin-3 and nm23 in breast carcinoma and related tissues (1994) Int J Cancer, 58, pp. 157-160
Weidner, N., Semple, J.P., Welch, W.R., Folkman, J., Tumor angiogenesis and metastasis-Correlation in invasive breast carcinoma (1991) N Engl J Med, 324, pp. 1-8
Rak, J., Filmus, J., Finkenzeller, G., Grugel, S., Marmé, D., Kerbel, R.S., Oncogenes as inducers of tumor angiogenesis (1995) Cancer Metast Rev, 14, pp. 263-277
Okada, A., Bellocq, J.P., Rouyer, N., Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas (1995) Proc Natl Acad Sci USA, 92, pp. 2730-2734
Anglard, P., Melot, T., Guérin, E., Thomas, G., Basset, P., Structure and promoter characterization of the human stromelysin-3 gene (1995) J Biol Chem, 270, pp. 20337-20344
Guérin, E., Ludwig, M.G., Basset, P., Anglard, P., Stromelysin-3 induction and interstitial collagenase repression by retinoic acid: Therapeutical implication of receptor-selective retinoids dissociating transactivation and AP-1 mediated-transrepression (1997) J Biol Chem, , in press
Gaire, M., Magbanua, Z., McDonnell, S., McNeil, L., Lovett, D.H., Matrisian, L.M., Structure and expression of the human gene for the matrix metalloproteinase matrilysin (1994) J Biol Chem, 269, pp. 2032-2040
Lafyatis, R., Kim, S.J., Angel, P., Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5′ activator binding site (1990) Mol Endocrinol, 4, pp. 973-980
Nicholson, R.C., Mader, S., Nagpal, S., Leid, M., Rochette-Egly, C., Chambon, P., Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an API binding site (1990) EMBO J, 9, pp. 4443-4454
Noël, A., Lefebvre, O., Maquoi, E., Stromelysin-3 expression promotes tumor take in nude mice (1996) J Clin Invest, 97, pp. 1924-1930
Witty, J.P., McDonnell, S., Newell, K.J., Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo (1994) Cancer Res, 54, pp. 4805-4812
Fowlkes, J.L., Enghild, J.J., Suzuki, K., Nagase, H., Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures (1994) J Biol Chem, 269, pp. 25742-25746
Levi, E., Fridman, R., Miao, H.Q., Ma, Y.S., Yayon, A., Vlodavsky, I., Matrix metalloproteinase 2 releases active solube ectodomain of fibroblast growth factor receptor 1 (1996) Proc Natl Acad Sci USA, 93, pp. 7069-7074
Broder, S., The challenge of cancer research (1993) Stem Cells, 11, pp. 3-8
Lippman, M.E., The development of biological therapies for breast cancer (1993) Science, 259, pp. 631-632
Brown, P.D., Matrix metalloproteinase inhibitors: A new class of anticancer agent (1993) Curr Opin Invest Drugs, 2, pp. 617-626
Davies, B., Brown, P.D., East, N., Crimmin, M.J., Balkwill, F.R., A synthetical matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts (1993) Cancer Res, 53, pp. 2087-2091
Chirivi, R.G.S., Garofalo, A., Crimmin, M.J., Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor (1994) Int J Cancer, 58, pp. 460-464
Naito, K., Kanbayashi, M., Makajima, S., Inhibition of growth of human tumor cells in nude mice by a metalloproteinase inhibitor (1994) Int J Cancer, 58, pp. 730-735
Wang, X., Fu, X., Brown, P.D., Crimmin, M.J., Hoffman, R.M., Matrix metalloproteinase inhibitor BB-94 (Batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice (1994) Cancer Res, 54, pp. 4726-4728
Eccles, S.A., Box, G.M., Court, W.J., Bone, E.A., Thomas, W., Brown, P.D., Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94) (1996) Cancer Res, 56, pp. 2815-2822
Low, J.A., Johnson, M.D., Bone, E.A., Dickson, R.B., The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice (1996) Clin Cancer Res, 2, pp. 1207-1214
Brown, P.D., Giavazzi, R., Matrix metalloproteinase inhibition: A review of anti-tumour activity (1995) Ann Oncol, 6, pp. 967-974
Beckett, R.P., Recent advances in the field of matrix metalloproteinase inhibitors (1996) Exp Opin Ther Patents, 6, pp. 1305-1315
Blundell, T.L., Metalloproteinase super-families and drug design (1994) Nature Struct Biol, 1, pp. 73-75
Hodgson, J., Remodeling MMPIs (1995) Bio Technology, 13, pp. 554-557
Stolow, M.A., Bauzon, D.D., Li, J., Identification and characterization of a novel collagenase in Xenopus laevis: Possible roles during frog development (1996) Mol Biol Cell, 7, pp. 1471-1483
Cossins, J., Dudgeon, T.J., Catlin, G., Ajh, G., Clements, J.M., Identification of MMP-18, a putative novel human matrix metalloproteinase (1996) Biochem Biophys Res Commun, 228, pp. 494-498
Pendas, A.M., Knauper, V., Puente, X.S., Identification and characterization of a novel matrix metalloproteinase with unique structural characteristics, chromosomal localization, and tissue distribution (1997) J Biol Chem, 272, pp. 4281-4286
Sedlacek, R., Mauch, S., Kolb, B., The novel matrix metalloproteinase RASI-1 is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis (1997) J Clin Invest, , in press
Bartlett, J.D., Simmer, J.P., Xue, J., Margolis, H.C., Moreno, E.C., Molecular cloning and mRNA tissue distribution of a novel matrix metalloproteinase isolated from porcine enamel organ (1996) Gene, 183, pp. 123-128
Takino, T., Sato, H., Shinagawa, A., Seiki, M., Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library (1995) J Biol Chem, 270, pp. 23013-23020
Will, H., Hinzmann, B., cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment (1995) Eur J Biochem, 231, pp. 602-608
Welch, A.R., Holman, C.M., Huber, M., Brenner, M.C., Browner, M.F., Van Wart, H.E., Understanding the P1′ specificity of the matrix metalloproteinases: Effect of S1′ pocket mutations in matrilysin and stromelysin-1 (1996) Biochemistry, 35, pp. 10103-10109
Reinemer, P., Grams, F., Huber, R., Structural implications for the role of the N terminus in the superactivation of collagenases. A crystallographic study (1994) FEBS Lett, 338, pp. 227-233
Bode, W., Gomis-Rüth, F.X., Stöcker, W., Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins' (1993) FEBS Lett, 331, pp. 134-140
Mouriquand, J., Mouriquand, C., Viala, C., Activité biologique des différentes zones obtenues par ultracentrifugation du facteur lacté de la souche de souris PS sur gradients préformés de ficoll (1970) Eur J Cancer, 6, pp. 115-124
Andres, A.C., Van Der Valk, M.A., Schönenberger, C.A., Ha-ras and c-myc oncogcne expression interferes with morphological and functional differentiation of mammary epithelial cells in single and double transgenic mice (1988) Genes Dev, 2, pp. 1486-1495